
QuantHealth uses AI to help pharma and biotech teams design and optimize clinical trials by predicting patient response and trial outcomes. The company combines a proprietary Large Healthcare Model with its Clinical Trial Simulator and Synthetic Evidence Generation Platform to run thousands of trial variations using over a trillion clinical and pharmacological data points. Its platform ingests patient-level data covering hundreds of millions of patients and hundreds of thousands of trials to generate synthetic evidence and endpoint predictions with reported 86% endpoint accuracy. QuantHealth operates as a B2B SaaS provider for clinical development and clinical operations teams, supporting indication selection, protocol feasibility, and endpoint optimization. The platform targets therapeutic areas including oncology and respiratory medicine to accelerate and de-risk drug development.

QuantHealth uses AI to help pharma and biotech teams design and optimize clinical trials by predicting patient response and trial outcomes. The company combines a proprietary Large Healthcare Model with its Clinical Trial Simulator and Synthetic Evidence Generation Platform to run thousands of trial variations using over a trillion clinical and pharmacological data points. Its platform ingests patient-level data covering hundreds of millions of patients and hundreds of thousands of trials to generate synthetic evidence and endpoint predictions with reported 86% endpoint accuracy. QuantHealth operates as a B2B SaaS provider for clinical development and clinical operations teams, supporting indication selection, protocol feasibility, and endpoint optimization. The platform targets therapeutic areas including oncology and respiratory medicine to accelerate and de-risk drug development.